Cargando…
The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species
Methyl-aminolevulinate-based photodynamic therapy (MAL-PDT) is utilised clinically for the treatment of non-melanoma skin cancers and pre-cancers and the hydroxypyridinone iron chelator, CP94, has successfully been demonstrated to increase MAL-PDT efficacy in an initial clinical pilot study. However...
Autores principales: | Dogra, Yuktee, Ferguson, Daniel C.J., Dodd, Nicholas J.F., Smerdon, Gary R., Curnow, Alison, Winyard, Paul G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961297/ https://www.ncbi.nlm.nih.gov/pubmed/27454766 http://dx.doi.org/10.1016/j.redox.2016.07.002 |
Ejemplares similares
-
Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents.
por: Curnow, A., et al.
Publicado: (1998) -
Hydroxypyridinone-Based Metal Chelators towards Ecotoxicity: Remediation and Biological Mechanisms
por: Santos, M. Amélia, et al.
Publicado: (2022) -
Polymeric iron chelators for enhancing 5‐aminolevulinic acid‐induced photodynamic therapy
por: Nomoto, Takahiro, et al.
Publicado: (2022) -
Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
por: Cusnir, Ruslan, et al.
Publicado: (2017) -
Tuning the properties of tris(hydroxypyridinone) ligands: efficient (68)Ga chelators for PET imaging
por: Imberti, Cinzia, et al.
Publicado: (2019)